These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27659101)

  • 1. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?
    Ackerman MJ; Priori SG; Dubin AM; Kowey P; Linker NJ; Slotwiner D; Triedman J; Van Hare GF; Gold MR
    Heart Rhythm; 2017 Jan; 14(1):e41-e44. PubMed ID: 27659101
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
    Leenhardt A; Lucet V; Denjoy I; Grau F; Ngoc DD; Coumel P
    Circulation; 1995 Mar; 91(5):1512-9. PubMed ID: 7867192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.
    Leren IS; Saberniak J; Majid E; Haland TF; Edvardsen T; Haugaa KH
    Heart Rhythm; 2016 Feb; 13(2):433-40. PubMed ID: 26432584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Peltenburg PJ; Kallas D; Bos JM; Lieve KVV; Franciosi S; Roston TM; Denjoy I; Sorensen KB; Ohno S; Roses-Noguer F; Aiba T; Maltret A; LaPage MJ; Atallah J; Giudicessi JR; Clur SB; Blom NA; Tanck M; Extramiana F; Kato K; Barc J; Borggrefe M; Behr ER; Sarquella-Brugada G; Tfelt-Hansen J; Zorio E; Swan H; Kammeraad JAE; Krahn AD; Davis A; Sacher F; Schwartz PJ; Roberts JD; Skinner JR; van den Berg MP; Kannankeril PJ; Drago F; Robyns T; Haugaa K; Tavacova T; Semsarian C; Till J; Probst V; Brugada R; Shimizu W; Horie M; Leenhardt A; Ackerman MJ; Sanatani S; van der Werf C; Wilde AAM
    Circulation; 2022 Feb; 145(5):333-344. PubMed ID: 34874747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.
    Balcells J; Rodríguez M; Pujol M; Iglesias J
    Pediatr Cardiol; 2004; 25(2):160-2. PubMed ID: 15046104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Claudio B; Alice M; Daniel S
    Mini Rev Med Chem; 2018; 18(6):476-482. PubMed ID: 28685702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart.
    Leite LR; Ponzi Pereira KR; Alessi SR; de Paola AA
    Arq Bras Cardiol; 2001 Jan; 76(1):63-74. PubMed ID: 11175485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
    Napolitano C; Bloise R; Monteforte N; Priori SG
    Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
    [No Abstract]   [Full Text] [Related]  

  • 9. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.
    Waddell-Smith KE; Ertresvaag KN; Li J; Chaudhuri K; Crawford JR; Hamill JK; Haydock D; Skinner JR;
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1151-8. PubMed ID: 26224781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term outcomes and factors for predicting ventricular arrhythmia in patients with catecholaminergic polymorphic ventricular tachycardia].
    Yu SY; Shen JH; Lu JP; Zhao DS; Zhang G; Geng J; Shan QJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):671-7. PubMed ID: 23965883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blockers normalize QT hysteresis in long QT syndrome.
    Krahn AD; Yee R; Chauhan V; Skanes AC; Wang J; Hegele RA; Klein GJ
    Am Heart J; 2002 Mar; 143(3):528-34. PubMed ID: 11868061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of pacing and beta-blockers in idiopathic repetitive polymorphic ventricular tachycardia.
    Pérez-Castellano N; Rodríguez JC; Medina O; Nieto V
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1304-7. PubMed ID: 11761421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta-blocker therapy on ventricular repolarization documented by 24-h electrocardiography in patients with type 1 long-QT syndrome.
    Viitasalo M; Oikarinen L; Swan H; Väänänen H; Järvenpää J; Hietanen H; Karjalainen J; Toivonen L
    J Am Coll Cardiol; 2006 Aug; 48(4):747-53. PubMed ID: 16904544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Brain-Heart Connection in Sympathetically Triggered Inherited Arrhythmia Syndromes.
    Winbo A; Paterson DJ
    Heart Lung Circ; 2020 Apr; 29(4):529-537. PubMed ID: 31959550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholaminergic Polymorphic Ventricular Tachycardia with QT Prolongation.
    Tanaka Y; Kawabata M; Scheinman MM; Hirao K
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1499-502. PubMed ID: 26256814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sports participation in long QT syndrome.
    Aziz PF; Saarel EV
    Cardiol Young; 2017 Jan; 27(S1):S43-S48. PubMed ID: 28084960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
    De Rosa G; Delogu AB; Piastra M; Chiaretti A; Bloise R; Priori SG
    Pediatr Emerg Care; 2004 Mar; 20(3):175-177. PubMed ID: 15094576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
    Padfield GJ; AlAhmari L; Lieve KV; AlAhmari T; Roston TM; Wilde AA; Krahn AD; Sanatani S
    Heart Rhythm; 2016 Feb; 13(2):609-13. PubMed ID: 26416620
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Rosso R; Kalman JM; Rogowski O; Diamant S; Birger A; Biner S; Belhassen B; Viskin S
    Heart Rhythm; 2007 Sep; 4(9):1149-54. PubMed ID: 17765612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.